Home » Topics » BioWorld

BioWorld
RSS

AMYLIN PLANS PHASE II FOR DIABETES DRUG

Jan. 14, 1993

BIOMATRIX AMENDS KABI PACT

Jan. 14, 1993

BAXTER BEGINS BLOOD SUBSTITUTE TRIALS

Jan. 14, 1993

SERAGEN REPORTS RESPONSE TO IL-2

Jan. 14, 1993

REGENERON BEGINS PHASE II TRIALS FOR ALS

Jan. 14, 1993

AIDS DRUG ENTERS PHASE II/III

Jan. 14, 1993

CONTROLLED-RELEASE ANTI-HYPERTENSIVE

Jan. 13, 1993

IMMUNOGEN FORMS 'PAPER' COMPANY

Jan. 13, 1993

ANTRIL DATA DUE IN FIRST QUARTER

Jan. 13, 1993

DEPOTECH RAISES $7.3 MILLION

Jan. 13, 1993

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...